Gilead Sciences Inc. (GILD) saw a big move last session, as the company’s shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GILD, as the stock is now down almost 18% in the past one-month time frame.
This biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
Gilead Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include Alexion Pharmaceuticals, Inc. (ALXN), Myriad Genetics Inc. (MYGN) and ANI Pharmaceuticals, Inc. (ANIP). ANI pharma and Myriad Genetics carry a Zacks Rank #1 (Strong Buy) while Alexion carries Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
Zacks Investment Research